Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism

被引:34
作者
Kamikura, Y
Wada, H
Nobori, T
Kobayashi, T
Sase, T
Nishikawa, M
Ishikura, K
Yamada, N
Abe, Y
Nishioka, J
Nakano, T
Shiku, H
机构
[1] Mie Univ, Dept Lab Med, Sch Med, Tsu, Mie 5148507, Japan
[2] Mie Univ, Dept Internal Med 2, Sch Med, Tsu, Mie 5148507, Japan
[3] Mie Univ, Dept Internal Med 1, Sch Med, Tsu, Mie 5148507, Japan
[4] Mie Univ, Cent Clin Labs, Sch Med, Tsu, Mie 5148507, Japan
关键词
TF; antigen; mRNA; leukocyte; DVT;
D O I
10.1016/j.thromres.2004.12.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue factor (TF) mRNA levels in leukocyte and TF antigen in plasma were examined in patients with deep vein thrombosis (DVT). Although TF mRNA Levels in leukocytes were higher in patients with DVT than in healthy volunteers, they were tower in patients with DVT than in those with solid cancer and those with disseminated intravascular coagulation (DIC). On the other hand, the plasma levels of TF antigens were markedly high in patients with DVT/pulmonary embolism (PE). Analysis of the role of underlying disease of DVT showed no significant difference in TF mRNA Levels and TF antigens among patients with solid cancer, post-surgical, other diseases and those free of underlying diseases. In patients with VTE, plasma levels of D-dimer, soluble fibrin, GE-XDP and plasminogen activator inhibitor-1 did not correlate with TF mRNA or TF antigen. In analysis of 18 patients with PE with and without DVT, TF mRNA levels in leukocytes correlated with the plasma levels of D-dimer. These findings suggest that TF in leukocytes is more likely to be involved in the development of thrombosis in PE than DVT. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:307 / 312
页数:6
相关论文
共 28 条
  • [1] Amirkhosravi A, 1996, THROMB HAEMOSTASIS, V75, P87
  • [2] RECOMBINANT TUMOR-NECROSIS-FACTOR INDUCES PROCOAGULANT ACTIVITY IN CULTURED HUMAN VASCULAR ENDOTHELIUM - CHARACTERIZATION AND COMPARISON WITH THE ACTIONS OF INTERLEUKIN-1
    BEVILACQUA, MP
    POBER, JS
    MAJEAU, GR
    FIERS, W
    COTRAN, RS
    GIMBRONE, MA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) : 4533 - 4537
  • [3] Cell biology of tissue factor, the principal initiator of blood coagulation
    Camerer, E
    Kolsto, AB
    Prydz, H
    [J]. THROMBOSIS RESEARCH, 1996, 81 (01) : 1 - 41
  • [4] CROSSMAN DC, 1990, J BIOL CHEM, V265, P9782
  • [5] The evaluation of suspected pulmonary embolism
    Fedullo, PF
    Tapson, VF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (13) : 1247 - 1256
  • [6] Franco RF, 2000, BLOOD, V96, P554
  • [7] Medical progress - Pulmonary embolism
    Goldhaber, SZ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (02) : 93 - 104
  • [8] REGULATION OF TISSUE FACTOR GENE-EXPRESSION IN THE MONOCYTE PROCOAGULANT RESPONSE TO ENDOTOXIN
    GREGORY, SA
    MORRISSEY, JH
    EDGINGTON, TS
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (06) : 2752 - 2755
  • [9] Heit JA, 2001, THROMB HAEMOSTASIS, V86, P452, DOI 10.1161/ATVBAHA.108.162545
  • [10] P-selectin and platelet-derived microparticles associated with monocyte activation markers in patients with pulmonary embolism
    Inami, N
    Nomura, S
    Kikuchi, H
    Kajiura, T
    Yamada, K
    Nakamori, H
    Takahashi, N
    Tsuda, N
    Hikosaka, M
    Masaki, M
    Iwasaka, T
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2003, 9 (04) : 309 - 316